Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company
Clinical trials sponsored by Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company, explained in plain language.
Now part of
Eli Lilly and Company
LLY
NYSE
A radiopharmaceutical company developing targeted cancer therapies, owned by Eli Lilly.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.